Is Rejuvia (unknown generic name) Sleep Spray safe to use for sleep improvement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rejuvia Sleep Spray: Safety and Efficacy Assessment

I cannot recommend Rejuvia Sleep Spray for sleep improvement due to the complete absence of safety data, efficacy evidence, and regulatory oversight for this specific product.

Critical Product Information Gap

  • No identifiable active ingredient: The generic name and formulation of Rejuvia Sleep Spray are unknown, making any safety or efficacy assessment impossible 1
  • No FDA approval or oversight: As a spray formulation marketed for sleep, this product likely falls under the unregulated dietary supplement category in the United States, where no regulatory agency oversees manufacturing quality, ingredient accuracy, or safety 2
  • Absence from clinical guidelines: Neither the American Academy of Sleep Medicine nor the American College of Physicians guidelines reference any sleep spray products as evidence-based treatments 1

Evidence-Based Alternatives You Should Use Instead

First-Line Treatment

  • Cognitive Behavioral Therapy for Insomnia (CBT-I) is the gold standard first-line treatment, demonstrating superior long-term efficacy compared to any pharmacotherapy 3

FDA-Approved Pharmacologic Options (When CBT-I Fails)

For sleep onset insomnia:

  • Zolpidem 10 mg: Reduces sleep latency by 29 minutes and improves total sleep time by 29 minutes compared to placebo 1
  • Eszopiclone 2-3 mg: Improves total sleep time by 28-57 minutes with moderate-to-large improvements in sleep quality 1

For sleep maintenance insomnia:

  • Low-dose doxepin 3-6 mg: Reduces wake after sleep onset by 22-23 minutes with favorable safety profile 1, 3
  • Suvorexant 10-20 mg: Reduces wake after sleep onset by 16-28 minutes, though with modest overall effect 1, 4

Why Common Over-the-Counter "Sleep Sprays" Are Problematic

If Rejuvia Contains Melatonin:

  • Not recommended by AASM: Melatonin shows only 9-minute reduction in sleep latency with small improvements in quality, insufficient for clinical recommendation 1
  • Unregulated dosing: Studies show marketed melatonin products vary wildly from labeled concentrations, with no quality control 2
  • Limited efficacy: While safe, melatonin's sleep-inducing ability is "detectable but modest for most people" 5, 2

If Rejuvia Contains Antihistamines (Diphenhydramine/Doxylamine):

  • Explicitly not recommended: The AASM found no improvement in sleep quality compared to placebo, with only 8-minute reduction in sleep latency 1
  • Significant harms in elderly: Associated with daytime drowsiness, falls, fractures, cognitive impairment, and anticholinergic effects 6, 7
  • Tolerance develops rapidly: Efficacy diminishes with continued use 7

If Rejuvia Contains Herbal Ingredients (Valerian, etc.):

  • Not recommended: Valerian shows only 9-minute reduction in sleep latency with no quality improvement, insufficient evidence for recommendation 1
  • Consider continuing only if already using: The Society for Perioperative Assessment notes valerian "appears safe" but provides "no objective benefit for sleep latency or quality" 1

Critical Safety Concerns with Unregulated Sleep Products

  • Unknown drug interactions: Without knowing the active ingredients, risk assessment for interactions with your current medications is impossible 6
  • Contamination risk: Unregulated supplements may contain unlisted ingredients, contaminants, or incorrect dosages 2
  • Delayed appropriate treatment: Using ineffective products postpones evidence-based interventions that could meaningfully improve your sleep and quality of life 3

What You Should Do Instead

  1. Pursue CBT-I first: This non-pharmacologic approach provides durable benefits without medication risks 3

  2. If pharmacotherapy needed, discuss FDA-approved options with your physician:

    • For difficulty falling asleep: Zolpidem or eszopiclone 1
    • For difficulty staying asleep: Low-dose doxepin or suvorexant 1, 3, 4
  3. Avoid over-the-counter sleep aids: Diphenhydramine, doxylamine, and most herbal products lack evidence and carry meaningful risks, particularly cognitive impairment and falls 1, 7

Common Pitfalls to Avoid

  • Do not assume "natural" or "spray" formulations are safer: Lack of regulation means unknown ingredients and concentrations 2
  • Do not use antihistamines chronically for sleep: Tolerance develops rapidly and harms outweigh minimal benefits 1, 7
  • Do not delay seeking proper evaluation: Chronic insomnia requires assessment for underlying causes and evidence-based treatment 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insomnia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lower Dose Orexin Inhibitors for Insomnia Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The use of non-prescription sleep products in the elderly.

International journal of geriatric psychiatry, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.